The Australian and New Zealand Urogenital and Prostate Cancer Trials Group was formed in 2008, bringing together a world-leading multidisciplinary team of doctors, nurses, allied health care professionals, scientists, researchers, and community representatives, all working in areas related to urogenital cancer.

ANZUP has members in every state and territory in Australia and New Zealand, with an increasing international membership.

ANZUP receives infrastructure funding from the Australian Government through Cancer Australia. Fundraising also remains an important part of ANZUP’s activities allowing us to support each and every new clinical trial.

Urogenital cancers, also called below the belt cancers, are those coming from the testicles, prostate, kidney, penis or bladder. ANZUP aims to improve outcomes for people affected by these cancers by exploring and defining priority areas in below the belt cancer research. We investigate which data deserves attention, which treatments hold promise for the future, which drugs should be tested in clinical trials and most importantly, we need to understand the main areas of concern of our patients.

By performing clinical trials we are able to generate new evidence for better treatments, or ways of providing other support.

Every meaningful advance in treatment has been the result of testing a new idea in a clinical trial.

Our members and investigators are widely dispersed and busy working in a range of disciplines. A trial idea only comes to fruition when we are able to provide opportunities for people to meet, explore the science, develop trial concepts, write and work through all the other documentation and processes. Then it is necessary to initiate, progress, monitor and report the trial results. All of this relies on the volunteered time of our members who are committed to making a difference to the lives of people affected by below the belt cancers.

See Clinical Trials for more information.